Medical Breakthrough: Nigeria Introduces Lenacapavir for HIV prevention

Lenacapavir, a long-acting injectable medication for HIV prevention, is now becoming available in Nigeria at an estimated subsidized cost of about ₦58,000.

Marketed under the brand name Yeztugo, lenacapavir is a breakthrough in HIV prevention because it is administered just once every six months.

How Does Lenacapavir Work?

Lenacapavir is used for Pre-Exposure Prophylaxis (PrEP) medication taken by HIV-negative individuals to reduce their risk of getting HIV.

Instead of:

You receive two injections per year for long-acting protection.

This makes it especially helpful for:

Is It 100% Effective?

Clinical trials have shown that lenacapavir is highly effective, with protection rates close to 100% in some study populations when taken correctly.

However, no medical intervention is officially described as “100% effective.” Protection depends on:

It significantly reduces risk but it does not replace regular testing and comprehensive prevention strategies.

Why Is It Cheaper in Nigeria?

Access in countries like Nigeria is supported through partnerships with global health organizations such as:

- Bill & Melinda Gates Foundation

- Clinton Health Access Initiative

- Unitaid

- Wits RHI

These organizations help subsidize pricing, improve access, and support distribution in low and middle income countries.

Important Things to Remember

✔ You must test HIV-negative before starting.

✔ It does not cure HIV.

✔ It does not protect against other sexually transmitted infections (STIs).

✔ Regular follow-up appointments are necessary.

Final Thoughts

Lenacapavir represents a powerful advancement in HIV prevention. Two injections per year can offer long-lasting protection and improve adherence compared to daily pills.

However, it should always be taken under medical supervision and as part of a comprehensive prevention strategy.

What do you think about this new development?